The diagnostic value of miR-340-5p in pediatric ulcerative colitis and its molecular mechanism by targeting MAP3K2 to

Fanting Meng1, Xianlong Han2, Lingxia Ge3,4

  • 1Department of Gastroenterology, Children's Hospital of Nanjing Medical University, Nanjing City, Jiangsu Province, 210000, China.

Hereditas
|November 19, 2025
PubMed

Insights

MicroRNA-340-5p is a potential diagnostic biomarker for pediatric ulcerative colitis (UC). It targets MAP3K2 to regulate inflammation, apoptosis, and oxidative stress in pediatric UC.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Pediatric ulcerative colitis (UC) incidence is rising, necessitating novel diagnostic biomarkers and understanding of molecular mechanisms.
  • Current research lacks specific biomarkers for early diagnosis and effective treatment of pediatric UC.

Purpose of the Study:

  • To investigate the diagnostic value of microRNA-340-5p (miR-340-5p) in pediatric UC.
  • To elucidate the molecular mechanism of miR-340-5p in pediatric UC by identifying its target, MAP3K2.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure miR-340-5p and MAP3K2 expression in 85 pediatric UC patients and 50 healthy controls.
  • Dual-luciferase assay to confirm the interaction between miR-340-5p and MAP3K2.
  • In vitro cell models (HT-29 cells) treated with dextran sulfate sodium (DSS) to assess cellular functions via flow cytometry, ELISA, and oxidative stress assays.

Main Results:

  • miR-340-5p was significantly downregulated in pediatric UC patients and negatively correlated with disease activity indices (PUCAI, CRP, ESR).
  • ROC curve analysis showed an area of 0.908 for miR-340-5p as a diagnostic marker.
  • miR-340-5p directly targets MAP3K2, suppressing its expression and mitigating DSS-induced apoptosis, inflammation (reduced TNF-α, IL-6, IL-17, IL-1β), and oxidative stress (reduced MDA, increased GSH).

Conclusions:

  • miR-340-5p demonstrates potential as a diagnostic biomarker for pediatric UC.
  • The miR-340-5p/MAP3K2 axis plays a crucial role in regulating apoptosis, inflammatory responses, and oxidative stress in pediatric UC.
  • Targeting the miR-340-5p/MAP3K2 pathway may offer therapeutic strategies for pediatric UC.